Medpage Today on MSN
Smoldering Myeloma Gets First FDA-Approved Therapy
The FDA on Thursday approved daratumumab-hyaluronidase (Darzalex Faspro) as the first drug for high-risk smoldering multiple ...
Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback